Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Natura: Artigo
Lingua:Russo
Pubblicazione: «FIRMA «SILICEA» LLC 2004-12-01
Serie:Российский кардиологический журнал
Soggetti:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Accesso online:https://russjcardiol.elpub.ru/jour/article/view/2326
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi